FDA Approves Oral Chemotherapy Onureg for Newly Diagnosed AML Patients in Remission
News
The U.S. Food and Drug Administration has approved Onureg, an oral formulation of the chemotherapy azacitidine, as a maintenance treatment for adults with newly diagnosed acute myeloid leukemia (AML) who ... Read more